Literature DB >> 28401776

Molecular Characteristics of the Envelope of Vertically Transmitted HIV-1 Strains from Infants with HIV Infection.

Manickam Ashokkumar1, Manohar Nesakumar1, Narayaniah Cheedarla1, K K Vidyavijayan1, Hemalatha Babu1, Srikanth P Tripathy1, Luke Elizabeth Hanna1.   

Abstract

Mother-to-child transmission (MTCT) of HIV offers a good opportunity to study the dynamics of early viral evolution in the host environment to which the virus has partially adapted. Such studies would throw light on the unique features of the infecting viruses, which will subsequently help to design preventive or therapeutic measures against the newly infecting and evolving strains of HIV. Therefore, we undertook a study to determine the genetic divergence of proviral envelope sequences from the HIV-infected infants (<2 years). Detailed analysis revealed unique features of potential N-linked glycosylation sites (PNGS) and their frequency of occurrence that built on the difference in length of the V1V2 region of the envelope sequences. Surprisingly, frequency of PNGS in the V5 region was found to revert rapidly, in about 75% of the sequences, which could surmise a fitness disadvantage in the variant forms. Further, a stable net charge was observed in the V2 and V3 regions prompting us to speculate on the established interaction of the transmitted variant with the integrin α4β7 receptor and R5 co-receptor, respectively. In brief, our observations suggest that differences in the length of the variable regions and variation in the frequency of PNGS in the envelope of the viruses obtained from very recently infected individuals in our population could be important characteristics of the unique quasispecies that is responsible for the spread of HIV in the early stages of infection in MTCT.

Entities:  

Keywords:  PNGS; infectivity fitness; variable region; vertical HIV-1 transmission; viral tropism

Mesh:

Substances:

Year:  2017        PMID: 28401776     DOI: 10.1089/AID.2016.0260

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.

Authors:  Manickam Ashokkumar; Shambhu G Aralaguppe; Srikanth P Tripathy; Luke Elizabeth Hanna; Ujjwal Neogi
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  Mapping of Neutralizing Antibody Epitopes on the Envelope of Viruses Obtained from Plasma Samples Exhibiting Broad Cross-Clade Neutralization Potential Against HIV-1.

Authors:  Narayanaiah Cheedarla; Jagadish Chandrabose Sundaramurthi; Babu Hemalatha; Brahmaiah Anangi; Manohar Nesakumar; Manickam Ashokkumar; K K Vidya Vijayan; Srikanth Prasad Tripathy; Soumya Swaminathan; S Kalyanaraman Vaniambadi; D Vadakkupattu Ramanathan; Luke Elizabeth Hanna
Journal:  AIDS Res Hum Retroviruses       Date:  2018-12-20       Impact factor: 2.205

3.  Humoral Response to the HIV-1 Envelope V2 Region in a Thai Early Acute Infection Cohort.

Authors:  Hung V Trinh; Neelakshi Gohain; Peter T Pham; Christopher Hamlin; Hongshuo Song; Eric Sanders-Buell; Meera Bose; Leigh A Eller; Swati Jain; Gherman Uritskiy; Venigalla B Rao; Sodsai Tovanabutra; Nelson L Michael; Merlin L Robb; M Gordon Joyce; Mangala Rao
Journal:  Cells       Date:  2019-04-19       Impact factor: 6.600

4.  Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage.

Authors:  Ana Borrajo; Alessandro Ranazzi; Michela Pollicita; Maria Concetta Bellocchi; Romina Salpini; Maria Vittoria Mauro; Francesca Ceccherini-Silberstein; Carlo Federico Perno; Valentina Svicher; Stefano Aquaro
Journal:  Medicina (Kaunas)       Date:  2019-06-21       Impact factor: 2.430

5.  In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha.

Authors:  Manickam Ashokkumar; Aanand Sonawane; Maike Sperk; Srikanth P Tripathy; Ujjwal Neogi; Luke Elizabeth Hanna
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.